rheumagen.com
Get leads like Rheumagen — and thousands more
Build targeted lists by tech stack, traffic, and more
RheumaGen: Engineering the End of Autoimmunity
A 7-person biotech startup is taking on the $100B+ autoimmune market with gene editing
While big pharma manages autoimmune diseases with immunosuppressants, RheumaGen is betting they can cure them. With just 7 employees and a bold mission to 'engineer the cure,' they're rewriting the rules of treatment at the genetic level.
"Managing symptoms is a business model. Curing diseases is a revolution."
The Science Bet
RheumaGen's approach is radically different from traditional biologics. Instead of suppressing the immune system (and exposing patients to infection risks), they're using gene editing to correct the underlying T-cell dysfunction. This isn't incremental improvement—it's a fundamental reimagining of autoimmune therapy. Their $1.1M in revenue likely comes from early-stage research partnerships or grants, a shoestring budget for such ambitious science.
The Lean Machine
With only 7 employees generating $1.1M, RheumaGen achieves $157K revenue per employee—exceptional for preclinical biotech. This isn't a company burning VC cash on lavish facilities. Richard Freed (CEO) and co-founder Brian Hart have built a surgical strike team, not a bloated research organization. Their LinkedIn presence is minimal, their traffic is negligible—this is a company heads-down in the lab, not marketing themselves to the world.
The keyword data reveals fascinating signals. They're tracking 'gene editing' financing terms and specific industry players like Curative Inc and Robert Mozayeni. This isn't random SEO—it's competitive intelligence. They're mapping the funding landscape and key opinion leaders in their space. The search volume for 'bci jordan' (1,240 monthly) suggests they're monitoring specific conferences or partnerships in the bioinformatics space.
- Gene editing approach targets T-cell dysfunction at source
- 7-person team with $157K revenue per employee
- 45% organic traffic suggests focused, intentional audience
- Tracking financing and key opinion leaders strategically
- Minimal web presence indicates lab-first priorities
The Verdict: High Risk, High Reward
RheumaGen is either a stealth-mode breakthrough or a science project that needs capital. Either way, they're playing the right game.
What tech stack does Rheumagen use?
How much traffic does Rheumagen get?
Traffic & Engagement
Traffic Sources
Where is Rheumagen's audience located?
What keywords does Rheumagen rank for?
5 keywordsHow is Rheumagen's SEO?
Meta Tags
RheumaGen
At RheumaGen, we aim to create a unique and revolutionary therapeutic pathway to cure autoimmune diseases at their source.
H1 Tags
Schema Types
What is Rheumagen's revenue?
Who works at Rheumagen?
Loading leads...
What do customers think of Rheumagen?
No Trustpilot reviews available for this company.
Frequently Asked Questions about Rheumagen
What is Rheumagen's Revenue?
What does Rheumagen do?
How fast is Rheumagen growing?
What technologies does Rheumagen use?
Who are Rheumagen's competitors?
Export Data
Unlock all exports
Download CSVs, JSONs & full reports
How to contact Rheumagen?
Social Profiles
Contact Information
Export rheumagen.com Data
Download the complete tech stack, analytics, leads, and company data for rheumagen.com in JSON or CSV format. Use it for your sales pipeline, competitive analysis, or research.
Raw JSON Data
Click "Show" to view the raw API response data
About rheumagen.com
At RheumaGen, we aim to create a unique and revolutionary therapeutic pathway to cure autoimmune diseases at their source.
Company Overview
rheumagen.com Social Media
Contact rheumagen.com
Email Addresses
Phone Numbers
Technology Stack
rheumagen.com uses 16 technologies across their website including Adobe Fonts, Google Fonts, PHP, WordPress, and more.
Fonts
Adobe Fonts, Google Fonts
Programming Languages
PHP
CMS
WordPress
Cloud & Hosting
Cloudflare
Privacy & Consent
CookieYes
Advertising
Microsoft Ads
Traffic & Audience
rheumagen.com receives approximately 1.2K monthly visitors and ranks #12,099,602 globally. The website has a bounce rate of 40% with visitors viewing an average of 1.9 pages per visit. Users spend an average of 0:52 on the site.
The majority of rheumagen.com's traffic comes from .
Frequently Asked Questions
What is rheumagen.com?
What technologies does rheumagen.com use?
How do I contact rheumagen.com?
What are rheumagen.com's social media accounts?
How popular is rheumagen.com?
Related Searches
This page provides publicly available information about rheumagen.com. Data is collected from various public sources and may not always be up to date. For the most accurate information, please visit rheumagen.com directly at https://rheumagen.com.